nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.154	0.206	CbGbCtD
Salmeterol—CYP3A7—Ifosfamide—testicular cancer	0.154	0.206	CbGbCtD
Salmeterol—CYP3A5—Ifosfamide—testicular cancer	0.116	0.154	CbGbCtD
Salmeterol—CYP2C8—Ifosfamide—testicular cancer	0.111	0.148	CbGbCtD
Salmeterol—CYP3A5—Etoposide—testicular cancer	0.0554	0.0738	CbGbCtD
Salmeterol—CYP2C8—Etoposide—testicular cancer	0.0532	0.071	CbGbCtD
Salmeterol—CYP3A4—Ifosfamide—testicular cancer	0.0452	0.0602	CbGbCtD
Salmeterol—CYP3A4—Vinblastine—testicular cancer	0.024	0.0319	CbGbCtD
Salmeterol—CYP3A4—Etoposide—testicular cancer	0.0216	0.0288	CbGbCtD
Salmeterol—CYP3A4—Doxorubicin—testicular cancer	0.0147	0.0196	CbGbCtD
Salmeterol—Hypertension—Etoposide—testicular cancer	0.000377	0.00151	CcSEcCtD
Salmeterol—Pain in extremity—Doxorubicin—testicular cancer	0.000376	0.00151	CcSEcCtD
Salmeterol—Asthma—Methotrexate—testicular cancer	0.000376	0.0015	CcSEcCtD
Salmeterol—Feeling abnormal—Ifosfamide—testicular cancer	0.000372	0.00149	CcSEcCtD
Salmeterol—Chest pain—Etoposide—testicular cancer	0.000372	0.00149	CcSEcCtD
Salmeterol—Nausea—Vinblastine—testicular cancer	0.000372	0.00149	CcSEcCtD
Salmeterol—Abdominal pain upper—Epirubicin—testicular cancer	0.000372	0.00149	CcSEcCtD
Salmeterol—Migraine—Doxorubicin—testicular cancer	0.00037	0.00148	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000369	0.00148	CcSEcCtD
Salmeterol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000369	0.00148	CcSEcCtD
Salmeterol—Discomfort—Etoposide—testicular cancer	0.000368	0.00147	CcSEcCtD
Salmeterol—Nasopharyngitis—Epirubicin—testicular cancer	0.000364	0.00146	CcSEcCtD
Salmeterol—Hypersensitivity—Dactinomycin—testicular cancer	0.000363	0.00145	CcSEcCtD
Salmeterol—Abdominal discomfort—Methotrexate—testicular cancer	0.00036	0.00144	CcSEcCtD
Salmeterol—Urticaria—Ifosfamide—testicular cancer	0.000359	0.00144	CcSEcCtD
Salmeterol—Abdominal pain—Ifosfamide—testicular cancer	0.000357	0.00143	CcSEcCtD
Salmeterol—Body temperature increased—Ifosfamide—testicular cancer	0.000357	0.00143	CcSEcCtD
Salmeterol—Anaphylactic shock—Etoposide—testicular cancer	0.000357	0.00143	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000355	0.00142	CcSEcCtD
Salmeterol—Infection—Etoposide—testicular cancer	0.000354	0.00142	CcSEcCtD
Salmeterol—Asthenia—Dactinomycin—testicular cancer	0.000354	0.00142	CcSEcCtD
Salmeterol—Influenza—Epirubicin—testicular cancer	0.000352	0.00141	CcSEcCtD
Salmeterol—Asthma—Epirubicin—testicular cancer	0.000352	0.00141	CcSEcCtD
Salmeterol—Paraesthesia—Cisplatin—testicular cancer	0.00035	0.0014	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000349	0.0014	CcSEcCtD
Salmeterol—Tachycardia—Etoposide—testicular cancer	0.000348	0.00139	CcSEcCtD
Salmeterol—Dyspnoea—Cisplatin—testicular cancer	0.000347	0.00139	CcSEcCtD
Salmeterol—Skin disorder—Etoposide—testicular cancer	0.000346	0.00139	CcSEcCtD
Salmeterol—Abdominal pain upper—Doxorubicin—testicular cancer	0.000344	0.00138	CcSEcCtD
Salmeterol—Bronchitis—Epirubicin—testicular cancer	0.000338	0.00135	CcSEcCtD
Salmeterol—Diarrhoea—Dactinomycin—testicular cancer	0.000337	0.00135	CcSEcCtD
Salmeterol—Pneumonia—Methotrexate—testicular cancer	0.000337	0.00135	CcSEcCtD
Salmeterol—Nasopharyngitis—Doxorubicin—testicular cancer	0.000337	0.00135	CcSEcCtD
Salmeterol—Vomiting—Bleomycin—testicular cancer	0.000336	0.00134	CcSEcCtD
Salmeterol—Infestation—Methotrexate—testicular cancer	0.000335	0.00134	CcSEcCtD
Salmeterol—Infestation NOS—Methotrexate—testicular cancer	0.000335	0.00134	CcSEcCtD
Salmeterol—Rash—Bleomycin—testicular cancer	0.000333	0.00133	CcSEcCtD
Salmeterol—Pain—Cisplatin—testicular cancer	0.000333	0.00133	CcSEcCtD
Salmeterol—Dermatitis—Bleomycin—testicular cancer	0.000333	0.00133	CcSEcCtD
Salmeterol—Hypersensitivity—Ifosfamide—testicular cancer	0.000333	0.00133	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000327	0.00131	CcSEcCtD
Salmeterol—Conjunctivitis—Methotrexate—testicular cancer	0.000326	0.0013	CcSEcCtD
Salmeterol—Asthma—Doxorubicin—testicular cancer	0.000325	0.0013	CcSEcCtD
Salmeterol—Influenza—Doxorubicin—testicular cancer	0.000325	0.0013	CcSEcCtD
Salmeterol—Asthenia—Ifosfamide—testicular cancer	0.000324	0.0013	CcSEcCtD
Salmeterol—Feeling abnormal—Cisplatin—testicular cancer	0.000321	0.00128	CcSEcCtD
Salmeterol—Paraesthesia—Etoposide—testicular cancer	0.00032	0.00128	CcSEcCtD
Salmeterol—Dyspnoea—Etoposide—testicular cancer	0.000318	0.00127	CcSEcCtD
Salmeterol—Hyperglycaemia—Epirubicin—testicular cancer	0.000317	0.00127	CcSEcCtD
Salmeterol—Epistaxis—Methotrexate—testicular cancer	0.000316	0.00126	CcSEcCtD
Salmeterol—Pneumonia—Epirubicin—testicular cancer	0.000315	0.00126	CcSEcCtD
Salmeterol—Nausea—Bleomycin—testicular cancer	0.000314	0.00126	CcSEcCtD
Salmeterol—Infestation NOS—Epirubicin—testicular cancer	0.000313	0.00125	CcSEcCtD
Salmeterol—Infestation—Epirubicin—testicular cancer	0.000313	0.00125	CcSEcCtD
Salmeterol—Vomiting—Dactinomycin—testicular cancer	0.000313	0.00125	CcSEcCtD
Salmeterol—Bronchitis—Doxorubicin—testicular cancer	0.000313	0.00125	CcSEcCtD
Salmeterol—Rash—Dactinomycin—testicular cancer	0.000311	0.00124	CcSEcCtD
Salmeterol—Diarrhoea—Ifosfamide—testicular cancer	0.000309	0.00124	CcSEcCtD
Salmeterol—Body temperature increased—Cisplatin—testicular cancer	0.000308	0.00123	CcSEcCtD
Salmeterol—Fatigue—Etoposide—testicular cancer	0.000307	0.00123	CcSEcCtD
Salmeterol—Pain—Etoposide—testicular cancer	0.000305	0.00122	CcSEcCtD
Salmeterol—Constipation—Etoposide—testicular cancer	0.000305	0.00122	CcSEcCtD
Salmeterol—Conjunctivitis—Epirubicin—testicular cancer	0.000305	0.00122	CcSEcCtD
Salmeterol—Urinary tract infection—Epirubicin—testicular cancer	0.000305	0.00122	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000302	0.00121	CcSEcCtD
Salmeterol—Dizziness—Ifosfamide—testicular cancer	0.000299	0.0012	CcSEcCtD
Salmeterol—Pharyngitis—Methotrexate—testicular cancer	0.000298	0.00119	CcSEcCtD
Salmeterol—Epistaxis—Epirubicin—testicular cancer	0.000296	0.00118	CcSEcCtD
Salmeterol—Sinusitis—Epirubicin—testicular cancer	0.000294	0.00118	CcSEcCtD
Salmeterol—Feeling abnormal—Etoposide—testicular cancer	0.000294	0.00118	CcSEcCtD
Salmeterol—Hyperglycaemia—Doxorubicin—testicular cancer	0.000293	0.00117	CcSEcCtD
Salmeterol—Nausea—Dactinomycin—testicular cancer	0.000293	0.00117	CcSEcCtD
Salmeterol—Pneumonia—Doxorubicin—testicular cancer	0.000292	0.00117	CcSEcCtD
Salmeterol—Gastrointestinal pain—Etoposide—testicular cancer	0.000292	0.00117	CcSEcCtD
Salmeterol—Infestation NOS—Doxorubicin—testicular cancer	0.00029	0.00116	CcSEcCtD
Salmeterol—Infestation—Doxorubicin—testicular cancer	0.00029	0.00116	CcSEcCtD
Salmeterol—Vomiting—Ifosfamide—testicular cancer	0.000287	0.00115	CcSEcCtD
Salmeterol—Hypersensitivity—Cisplatin—testicular cancer	0.000287	0.00115	CcSEcCtD
Salmeterol—Rash—Ifosfamide—testicular cancer	0.000285	0.00114	CcSEcCtD
Salmeterol—Dermatitis—Ifosfamide—testicular cancer	0.000284	0.00114	CcSEcCtD
Salmeterol—Urticaria—Etoposide—testicular cancer	0.000283	0.00113	CcSEcCtD
Salmeterol—Rhinitis—Epirubicin—testicular cancer	0.000282	0.00113	CcSEcCtD
Salmeterol—Abdominal pain—Etoposide—testicular cancer	0.000282	0.00113	CcSEcCtD
Salmeterol—Body temperature increased—Etoposide—testicular cancer	0.000282	0.00113	CcSEcCtD
Salmeterol—Urinary tract infection—Doxorubicin—testicular cancer	0.000282	0.00113	CcSEcCtD
Salmeterol—Conjunctivitis—Doxorubicin—testicular cancer	0.000282	0.00113	CcSEcCtD
Salmeterol—Asthenia—Cisplatin—testicular cancer	0.000279	0.00112	CcSEcCtD
Salmeterol—Pharyngitis—Epirubicin—testicular cancer	0.000279	0.00112	CcSEcCtD
Salmeterol—Cardiac disorder—Methotrexate—testicular cancer	0.000279	0.00112	CcSEcCtD
Salmeterol—Connective tissue disorder—Epirubicin—testicular cancer	0.000277	0.00111	CcSEcCtD
Salmeterol—Epistaxis—Doxorubicin—testicular cancer	0.000274	0.00109	CcSEcCtD
Salmeterol—Sinusitis—Doxorubicin—testicular cancer	0.000272	0.00109	CcSEcCtD
Salmeterol—Immune system disorder—Methotrexate—testicular cancer	0.000272	0.00109	CcSEcCtD
Salmeterol—Mediastinal disorder—Methotrexate—testicular cancer	0.000271	0.00108	CcSEcCtD
Salmeterol—Nausea—Ifosfamide—testicular cancer	0.000268	0.00107	CcSEcCtD
Salmeterol—Diarrhoea—Cisplatin—testicular cancer	0.000266	0.00107	CcSEcCtD
Salmeterol—Mental disorder—Methotrexate—testicular cancer	0.000263	0.00105	CcSEcCtD
Salmeterol—Hypersensitivity—Etoposide—testicular cancer	0.000263	0.00105	CcSEcCtD
Salmeterol—Malnutrition—Methotrexate—testicular cancer	0.000262	0.00105	CcSEcCtD
Salmeterol—Cardiac disorder—Epirubicin—testicular cancer	0.000261	0.00105	CcSEcCtD
Salmeterol—Rhinitis—Doxorubicin—testicular cancer	0.000261	0.00104	CcSEcCtD
Salmeterol—Pharyngitis—Doxorubicin—testicular cancer	0.000258	0.00103	CcSEcCtD
Salmeterol—Asthenia—Etoposide—testicular cancer	0.000256	0.00102	CcSEcCtD
Salmeterol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000256	0.00102	CcSEcCtD
Salmeterol—Immune system disorder—Epirubicin—testicular cancer	0.000254	0.00102	CcSEcCtD
Salmeterol—Mediastinal disorder—Epirubicin—testicular cancer	0.000254	0.00102	CcSEcCtD
Salmeterol—Back pain—Methotrexate—testicular cancer	0.000253	0.00101	CcSEcCtD
Salmeterol—Arrhythmia—Epirubicin—testicular cancer	0.000251	0.00101	CcSEcCtD
Salmeterol—Vomiting—Cisplatin—testicular cancer	0.000248	0.000991	CcSEcCtD
Salmeterol—Mental disorder—Epirubicin—testicular cancer	0.000247	0.000987	CcSEcCtD
Salmeterol—Rash—Cisplatin—testicular cancer	0.000245	0.000982	CcSEcCtD
Salmeterol—Dermatitis—Cisplatin—testicular cancer	0.000245	0.000982	CcSEcCtD
Salmeterol—Malnutrition—Epirubicin—testicular cancer	0.000245	0.00098	CcSEcCtD
Salmeterol—Diarrhoea—Etoposide—testicular cancer	0.000244	0.000977	CcSEcCtD
Salmeterol—Ill-defined disorder—Methotrexate—testicular cancer	0.000243	0.000972	CcSEcCtD
Salmeterol—Cardiac disorder—Doxorubicin—testicular cancer	0.000242	0.000967	CcSEcCtD
Salmeterol—Tension—Epirubicin—testicular cancer	0.00024	0.000962	CcSEcCtD
Salmeterol—Nervousness—Epirubicin—testicular cancer	0.000238	0.000952	CcSEcCtD
Salmeterol—Back pain—Epirubicin—testicular cancer	0.000237	0.000948	CcSEcCtD
Salmeterol—Malaise—Methotrexate—testicular cancer	0.000236	0.000945	CcSEcCtD
Salmeterol—Dizziness—Etoposide—testicular cancer	0.000236	0.000944	CcSEcCtD
Salmeterol—Muscle spasms—Epirubicin—testicular cancer	0.000236	0.000943	CcSEcCtD
Salmeterol—Immune system disorder—Doxorubicin—testicular cancer	0.000235	0.000941	CcSEcCtD
Salmeterol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000235	0.000939	CcSEcCtD
Salmeterol—Arrhythmia—Doxorubicin—testicular cancer	0.000233	0.000931	CcSEcCtD
Salmeterol—Nausea—Cisplatin—testicular cancer	0.000231	0.000926	CcSEcCtD
Salmeterol—Cough—Methotrexate—testicular cancer	0.000228	0.000914	CcSEcCtD
Salmeterol—Mental disorder—Doxorubicin—testicular cancer	0.000228	0.000913	CcSEcCtD
Salmeterol—Ill-defined disorder—Epirubicin—testicular cancer	0.000227	0.00091	CcSEcCtD
Salmeterol—Vomiting—Etoposide—testicular cancer	0.000227	0.000908	CcSEcCtD
Salmeterol—Malnutrition—Doxorubicin—testicular cancer	0.000227	0.000907	CcSEcCtD
Salmeterol—Agitation—Epirubicin—testicular cancer	0.000225	0.000901	CcSEcCtD
Salmeterol—Rash—Etoposide—testicular cancer	0.000225	0.0009	CcSEcCtD
Salmeterol—Dermatitis—Etoposide—testicular cancer	0.000225	0.000899	CcSEcCtD
Salmeterol—Headache—Etoposide—testicular cancer	0.000223	0.000894	CcSEcCtD
Salmeterol—Arthralgia—Methotrexate—testicular cancer	0.000223	0.000892	CcSEcCtD
Salmeterol—Myalgia—Methotrexate—testicular cancer	0.000223	0.000892	CcSEcCtD
Salmeterol—Chest pain—Methotrexate—testicular cancer	0.000223	0.000892	CcSEcCtD
Salmeterol—Tension—Doxorubicin—testicular cancer	0.000222	0.00089	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000221	0.000886	CcSEcCtD
Salmeterol—Malaise—Epirubicin—testicular cancer	0.000221	0.000884	CcSEcCtD
Salmeterol—Discomfort—Methotrexate—testicular cancer	0.00022	0.000881	CcSEcCtD
Salmeterol—Nervousness—Doxorubicin—testicular cancer	0.00022	0.000881	CcSEcCtD
Salmeterol—Back pain—Doxorubicin—testicular cancer	0.000219	0.000878	CcSEcCtD
Salmeterol—Muscle spasms—Doxorubicin—testicular cancer	0.000218	0.000872	CcSEcCtD
Salmeterol—Palpitations—Epirubicin—testicular cancer	0.000216	0.000866	CcSEcCtD
Salmeterol—Cough—Epirubicin—testicular cancer	0.000214	0.000856	CcSEcCtD
Salmeterol—Anaphylactic shock—Methotrexate—testicular cancer	0.000214	0.000855	CcSEcCtD
Salmeterol—Infection—Methotrexate—testicular cancer	0.000212	0.000849	CcSEcCtD
Salmeterol—Nausea—Etoposide—testicular cancer	0.000212	0.000848	CcSEcCtD
Salmeterol—Hypertension—Epirubicin—testicular cancer	0.000211	0.000847	CcSEcCtD
Salmeterol—Ill-defined disorder—Doxorubicin—testicular cancer	0.00021	0.000842	CcSEcCtD
Salmeterol—Nervous system disorder—Methotrexate—testicular cancer	0.00021	0.000839	CcSEcCtD
Salmeterol—Chest pain—Epirubicin—testicular cancer	0.000209	0.000835	CcSEcCtD
Salmeterol—Myalgia—Epirubicin—testicular cancer	0.000209	0.000835	CcSEcCtD
Salmeterol—Arthralgia—Epirubicin—testicular cancer	0.000209	0.000835	CcSEcCtD
Salmeterol—Agitation—Doxorubicin—testicular cancer	0.000208	0.000834	CcSEcCtD
Salmeterol—Anxiety—Epirubicin—testicular cancer	0.000208	0.000832	CcSEcCtD
Salmeterol—Skin disorder—Methotrexate—testicular cancer	0.000208	0.000831	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000207	0.000829	CcSEcCtD
Salmeterol—Discomfort—Epirubicin—testicular cancer	0.000206	0.000825	CcSEcCtD
Salmeterol—Malaise—Doxorubicin—testicular cancer	0.000204	0.000818	CcSEcCtD
Salmeterol—Dry mouth—Epirubicin—testicular cancer	0.000204	0.000816	CcSEcCtD
Salmeterol—Palpitations—Doxorubicin—testicular cancer	0.0002	0.000802	CcSEcCtD
Salmeterol—Oedema—Epirubicin—testicular cancer	0.0002	0.0008	CcSEcCtD
Salmeterol—Anaphylactic shock—Epirubicin—testicular cancer	0.0002	0.0008	CcSEcCtD
Salmeterol—Infection—Epirubicin—testicular cancer	0.000199	0.000795	CcSEcCtD
Salmeterol—Cough—Doxorubicin—testicular cancer	0.000198	0.000792	CcSEcCtD
Salmeterol—Nervous system disorder—Epirubicin—testicular cancer	0.000196	0.000785	CcSEcCtD
Salmeterol—Hypertension—Doxorubicin—testicular cancer	0.000196	0.000783	CcSEcCtD
Salmeterol—Tachycardia—Epirubicin—testicular cancer	0.000195	0.000781	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000195	0.000779	CcSEcCtD
Salmeterol—Skin disorder—Epirubicin—testicular cancer	0.000194	0.000777	CcSEcCtD
Salmeterol—Insomnia—Methotrexate—testicular cancer	0.000193	0.000773	CcSEcCtD
Salmeterol—Chest pain—Doxorubicin—testicular cancer	0.000193	0.000772	CcSEcCtD
Salmeterol—Myalgia—Doxorubicin—testicular cancer	0.000193	0.000772	CcSEcCtD
Salmeterol—Arthralgia—Doxorubicin—testicular cancer	0.000193	0.000772	CcSEcCtD
Salmeterol—Anxiety—Doxorubicin—testicular cancer	0.000192	0.00077	CcSEcCtD
Salmeterol—Paraesthesia—Methotrexate—testicular cancer	0.000192	0.000768	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000192	0.000767	CcSEcCtD
Salmeterol—Discomfort—Doxorubicin—testicular cancer	0.000191	0.000763	CcSEcCtD
Salmeterol—Dyspnoea—Methotrexate—testicular cancer	0.00019	0.000762	CcSEcCtD
Salmeterol—Dry mouth—Doxorubicin—testicular cancer	0.000189	0.000755	CcSEcCtD
Salmeterol—Dyspepsia—Methotrexate—testicular cancer	0.000188	0.000753	CcSEcCtD
Salmeterol—Anaphylactic shock—Doxorubicin—testicular cancer	0.000185	0.00074	CcSEcCtD
Salmeterol—Oedema—Doxorubicin—testicular cancer	0.000185	0.00074	CcSEcCtD
Salmeterol—Fatigue—Methotrexate—testicular cancer	0.000184	0.000737	CcSEcCtD
Salmeterol—Infection—Doxorubicin—testicular cancer	0.000184	0.000736	CcSEcCtD
Salmeterol—Pain—Methotrexate—testicular cancer	0.000183	0.000731	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000182	0.000729	CcSEcCtD
Salmeterol—Nervous system disorder—Doxorubicin—testicular cancer	0.000181	0.000726	CcSEcCtD
Salmeterol—Insomnia—Epirubicin—testicular cancer	0.000181	0.000724	CcSEcCtD
Salmeterol—Tachycardia—Doxorubicin—testicular cancer	0.000181	0.000723	CcSEcCtD
Salmeterol—Skin disorder—Doxorubicin—testicular cancer	0.00018	0.000719	CcSEcCtD
Salmeterol—Paraesthesia—Epirubicin—testicular cancer	0.00018	0.000719	CcSEcCtD
Salmeterol—Dyspnoea—Epirubicin—testicular cancer	0.000178	0.000713	CcSEcCtD
Salmeterol—Feeling abnormal—Methotrexate—testicular cancer	0.000176	0.000705	CcSEcCtD
Salmeterol—Dyspepsia—Epirubicin—testicular cancer	0.000176	0.000704	CcSEcCtD
Salmeterol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000175	0.000699	CcSEcCtD
Salmeterol—Fatigue—Epirubicin—testicular cancer	0.000172	0.00069	CcSEcCtD
Salmeterol—Constipation—Epirubicin—testicular cancer	0.000171	0.000684	CcSEcCtD
Salmeterol—Pain—Epirubicin—testicular cancer	0.000171	0.000684	CcSEcCtD
Salmeterol—Urticaria—Methotrexate—testicular cancer	0.00017	0.000679	CcSEcCtD
Salmeterol—Abdominal pain—Methotrexate—testicular cancer	0.000169	0.000676	CcSEcCtD
Salmeterol—Body temperature increased—Methotrexate—testicular cancer	0.000169	0.000676	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000169	0.000675	CcSEcCtD
Salmeterol—Insomnia—Doxorubicin—testicular cancer	0.000167	0.00067	CcSEcCtD
Salmeterol—Paraesthesia—Doxorubicin—testicular cancer	0.000166	0.000665	CcSEcCtD
Salmeterol—Dyspnoea—Doxorubicin—testicular cancer	0.000165	0.00066	CcSEcCtD
Salmeterol—Feeling abnormal—Epirubicin—testicular cancer	0.000165	0.000659	CcSEcCtD
Salmeterol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000163	0.000654	CcSEcCtD
Salmeterol—Dyspepsia—Doxorubicin—testicular cancer	0.000163	0.000652	CcSEcCtD
Salmeterol—Fatigue—Doxorubicin—testicular cancer	0.000159	0.000638	CcSEcCtD
Salmeterol—Urticaria—Epirubicin—testicular cancer	0.000159	0.000636	CcSEcCtD
Salmeterol—Pain—Doxorubicin—testicular cancer	0.000158	0.000633	CcSEcCtD
Salmeterol—Constipation—Doxorubicin—testicular cancer	0.000158	0.000633	CcSEcCtD
Salmeterol—Body temperature increased—Epirubicin—testicular cancer	0.000158	0.000633	CcSEcCtD
Salmeterol—Abdominal pain—Epirubicin—testicular cancer	0.000158	0.000633	CcSEcCtD
Salmeterol—Hypersensitivity—Methotrexate—testicular cancer	0.000157	0.00063	CcSEcCtD
Salmeterol—Asthenia—Methotrexate—testicular cancer	0.000153	0.000613	CcSEcCtD
Salmeterol—Feeling abnormal—Doxorubicin—testicular cancer	0.000152	0.00061	CcSEcCtD
Salmeterol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000151	0.000605	CcSEcCtD
Salmeterol—Hypersensitivity—Epirubicin—testicular cancer	0.000147	0.00059	CcSEcCtD
Salmeterol—Urticaria—Doxorubicin—testicular cancer	0.000147	0.000588	CcSEcCtD
Salmeterol—Abdominal pain—Doxorubicin—testicular cancer	0.000146	0.000585	CcSEcCtD
Salmeterol—Body temperature increased—Doxorubicin—testicular cancer	0.000146	0.000585	CcSEcCtD
Salmeterol—Diarrhoea—Methotrexate—testicular cancer	0.000146	0.000585	CcSEcCtD
Salmeterol—Asthenia—Epirubicin—testicular cancer	0.000143	0.000574	CcSEcCtD
Salmeterol—Dizziness—Methotrexate—testicular cancer	0.000141	0.000565	CcSEcCtD
Salmeterol—Diarrhoea—Epirubicin—testicular cancer	0.000137	0.000548	CcSEcCtD
Salmeterol—Hypersensitivity—Doxorubicin—testicular cancer	0.000136	0.000546	CcSEcCtD
Salmeterol—Vomiting—Methotrexate—testicular cancer	0.000136	0.000544	CcSEcCtD
Salmeterol—Rash—Methotrexate—testicular cancer	0.000135	0.000539	CcSEcCtD
Salmeterol—Dermatitis—Methotrexate—testicular cancer	0.000135	0.000539	CcSEcCtD
Salmeterol—Headache—Methotrexate—testicular cancer	0.000134	0.000536	CcSEcCtD
Salmeterol—Asthenia—Doxorubicin—testicular cancer	0.000133	0.000531	CcSEcCtD
Salmeterol—Dizziness—Epirubicin—testicular cancer	0.000132	0.000529	CcSEcCtD
Salmeterol—Vomiting—Epirubicin—testicular cancer	0.000127	0.000509	CcSEcCtD
Salmeterol—Nausea—Methotrexate—testicular cancer	0.000127	0.000508	CcSEcCtD
Salmeterol—Diarrhoea—Doxorubicin—testicular cancer	0.000127	0.000507	CcSEcCtD
Salmeterol—Rash—Epirubicin—testicular cancer	0.000126	0.000505	CcSEcCtD
Salmeterol—Dermatitis—Epirubicin—testicular cancer	0.000126	0.000504	CcSEcCtD
Salmeterol—Headache—Epirubicin—testicular cancer	0.000125	0.000501	CcSEcCtD
Salmeterol—Dizziness—Doxorubicin—testicular cancer	0.000122	0.00049	CcSEcCtD
Salmeterol—Nausea—Epirubicin—testicular cancer	0.000119	0.000475	CcSEcCtD
Salmeterol—Vomiting—Doxorubicin—testicular cancer	0.000118	0.000471	CcSEcCtD
Salmeterol—Rash—Doxorubicin—testicular cancer	0.000117	0.000467	CcSEcCtD
Salmeterol—Dermatitis—Doxorubicin—testicular cancer	0.000117	0.000466	CcSEcCtD
Salmeterol—Headache—Doxorubicin—testicular cancer	0.000116	0.000464	CcSEcCtD
Salmeterol—Nausea—Doxorubicin—testicular cancer	0.00011	0.00044	CcSEcCtD
